Published On: Fri, Aug 20th, 2021
World | By

UK’s Regulator Approves First Drug Designed Specifically to Tackle COVID-19on August 20, 2021 at 11:16 am

Share This

The medicines regulator has approved use of the first treatment in the UK using man-made antibodies to prevent and fight COVID-19. Health Secretary Sajid Javid said approval of the first drug designed specifically for COVID-19 in the country is “fantastic news” and he hopes it can be rolled out for patients on the NHS “as soon as possible.” The Medicines and Healthcare products Regulatory Agency (MHRA) said the clinical trial data they had assessed has shown Ronapreve may be used to prevent infection, treat symptoms of acute COVID-19 infection, and can reduce the likelihood of being admitted to hospital due to the virus. Trials took place before widespread vaccination and before the emergence of virus variants. The drug, previously known as REGN-Cov2, was given to former U.S. President Donald Trump when he was admitted to hospital with COVID-19 last year. It is the first monoclonal antibody combination product approved for … Save 10% on Citrus trees with code CITRUS

About the Author